United Health Products, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
UEECStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
FORM 10-Q QUARTERLY REPORT
TABLE OF CONTENTS
| PAGE | |||
|---|---|---|---|
| PART I. FINANCIAL INFORMATION | |||
| Item 1. · Financial Statements (Unaudited) | |||
| Condensed Balance Sheets as of June 30, 2026 (unaudited) and December 31, 2025 | 3 | ||
| Condensed Statements of Operations for the Three and Six Months Ended June 30, 2026 and June 30, 2025 (unaudited) | 4 | ||
| Condensed Statement of Stockholders’ Deficiency for the Three and Six Months Ended June 30, 2026 and June 30, 2025 (unaudited) | 5 | ||
| Condensed Statements of Cash Flows for the Six Months Ended June 30, 2026 and June 30, 2025 (unaudited) | 6 | ||
| Notes to Condensed Financial Statements (unaudited) | 7 | ||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 19 | |
| Item 3. | Quantitative and Qualitative Disclosures | 27 | |
| Item 4. | Controls and Procedures | 27 | |
| PART II. OTHER INFORMATION | |||
| Item 1. | Legal Proceedings | 28 | |
| Item 1A. | Risk Factors | 28 | |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 28 | |
| Item 3. | Defaults Upon Senior Securities | 28 | |
| Item 4. | Mine Safety Disclosures | 28 | |
| Item 5. | Other Information | 28 | |
| Item 6. | Exhibits | 29 | |
| SIGNATURES | 31 | ||
UNITED HEALTH PRODUCTS, INC.
Condensed Balance Sheets
| June 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | (Restated) | |
| ASSETS | ||
| Current Assets | ||
| Cash and cash equivalents | $24,495 | $65,249 |
| Prepaid and other current assets | 40,169 | 40,143 |
| Total current assets | 64,664 | 105,392 |
| Deferred offering costs | 161,046 | 169,582 |
| Operating lease right-of-use asset | - | 14,574 |
| Security deposit | - | 2,850 |
| Patents, net | 22,275 | 24,300 |
| TOTAL ASSETS | $247,985 | $316,698 |
| Current Liabilities | ||
| Accounts payable and accrued expenses | $1,355,199 | $1,160,776 |
| Accrued liabilities - related parties | 310,498 | 255,573 |
| Accrued compensation | 541,067 | 699,767 |
| Operating lease liability - current | - | 15,157 |
| Notes payable | 80,924 | - |
| Convertible notes payable – related party, net of debt discount | 500,000 | 500,000 |
| Convertible notes payable, net of debt discount | 1,247,804 | 1,279,149 |
| Derivative liabilities | 152,742 | 141,248 |
| Total current liabilities | 4,188,234 | 4,051,670 |
| Notes payable – related party, long-term, net of debt discount | 502,567 | 250,000 |
| TOTAL LIABILITIES | 4,690,801 | 4,301,670 |
| Commitments and Contingencies | - | - |
| Stockholders’ Deficit | ||
| Series A Convertible Preferred Stock - $0.001 par value, 1,000,000 shares Authorized and 0 shares issued and outstanding | - | - |
| Common Stock - $0.001 par value, 300,000,000 shares Authorized, 261,585,588 and 258,690,253 shares issued and outstanding at June 30, 2026 and December 31, 2025 | 261,585 | 258,690 |
| Additional Paid-In Capital | 77,374,393 | 77,235,150 |
| Accumulated Deficit | (82,078,794) | (81,478,812) |
| Total Stockholders’ Deficit | (4,442,816) | (3,984,972) |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $247,985 | $316,698 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.